CleanSlate Centers, a leading outpatient provider of medication-assisted treatment (MAT), has promoted Dr. Claudie Jimenez to chief medical officer. In her new role, Dr. Jimenez will oversee all medical initiatives at CleanSlate, including behavioral health programs, and lead the integration of behavioral health counselors with medical providers to ensure patients receive comprehensive, coordinated care. Her leadership will be critical in advancing the quality and accessibility of Substance Use Disorder services across CleanSlate’s locations.
Founded in 2009, CleanSlate Centers provides integrated MAT alongside behavioral health therapies and currently operates in 10 states. The organization emphasizes a patient-focused approach, combining evidence-based Substance Use Disorder services with counseling and behavioral health interventions. “Dr. Jimenez’s passion to serve our patient population is critical to CleanSlate Centers as we continue to combat the nation’s substance use epidemic through our holistic treatment approach,” said CleanSlate CEO Chris Bove. “Her expertise is vital as we expand her role to include oversight of our behavioral health initiatives, giving our patients the best hope of success on their recovery journey.”
Dr. Jimenez has over five years of experience at CleanSlate, previously serving as senior vice president of medical operations, regional medical director, and area medical director. Before joining CleanSlate, she was the medical director for Harlem East Life Plan. In her new position, she will play a central role in enhancing integrated Substance Use Disorder services, ensuring that patients’ mental health needs are addressed alongside their recovery from addiction.
CleanSlate’s Holistic Approach to Substance Use Disorder Services
CleanSlate Centers has built its reputation on delivering integrated care that treats both substance use disorders and underlying behavioral health conditions. Medication-assisted treatment, which includes FDA-approved medications like buprenorphine or naltrexone, is combined with counseling and therapy to address the psychological, social, and emotional aspects of addiction. By integrating behavioral health counselors with medical providers, CleanSlate aims to make Substance Use Disorder services more coordinated and accessible, improving recovery outcomes and patient satisfaction.
Patients benefit from a structured approach where treatment plans are personalized and continuously monitored. This approach ensures that Substance Use Disorder services are not delivered in isolation but are part of a broader strategy that addresses co-occurring mental health conditions, relapse prevention, and long-term wellness.
Leadership Changes Across the Behavioral Health Industry
CleanSlate’s promotion of Dr. Jimenez reflects a wider trend in behavioral health toward integrating clinical expertise with executive leadership. Several other organizations have recently announced notable executive changes that emphasize innovation in patient care.
Cognoa Appoints Dr. Sharief Taraman as CEO
Pediatric behavioral health company Cognoa named Dr. Sharief Taraman as its next CEO. Taraman previously served as the company’s chief medical officer and played a key role in clinical evidence generation that earned FDA breakthrough designation for Cognoa’s autism detection tool, Canvas Dx. He now leads the company in commercializing the tool, which helps providers deliver early autism diagnosis for children ages 18 to 72 months.
AMFM Healthcare Names Ted Guastello CEO
AMFM Healthcare, which provides residential and outpatient mental health and Substance Use Disorder services, promoted Ted Guastello to CEO. Guastello joined the organization in 2020 as chief strategy officer and was instrumental in expanding the company into Washington and Virginia. He also led the development of AMFM’s telehealth platform, Mission Connection, enabling continued access to mental health and Substance Use Disorder services during the pandemic. As CEO, he will oversee the launch of Mission Prep, an adolescent mental health program slated for early 2023.
Field Trip Health Strengthens Executive Team
Psychedelic therapy company Field Trip Health & Wellness appointed Stacey Hoisak as senior vice president and general counsel, and Dr. Monique Moller as vice president of integrative health. Their expertise will support the company’s holistic mental health approach, complementing Substance Use Disorder services and broader behavioral health programs. Hoisak’s corporate and legal experience and Dr. Moller’s clinical background enhance Field Trip’s ability to integrate medicine, technology, and community-based support to improve patient outcomes.
The Growing Emphasis on Integrated Care
The promotion of Dr. Jimenez and executive hires across the behavioral health industry highlight the increasing focus on integrated, patient-centered care. Organizations are recognizing that high-quality Substance Use Disorder services must be combined with mental health care, counseling, and innovative treatment approaches to maximize recovery outcomes. Leaders like Dr. Jimenez are at the forefront of this movement, ensuring that patients have access to coordinated, comprehensive care that addresses all aspects of recovery.
As CleanSlate continues to expand its behavioral health programs under Dr. Jimenez’s leadership, patients can expect improved access to evidence-based Substance Use Disorder services, personalized treatment plans, and an integrated approach that addresses both medical and behavioral health needs. These executive moves signal a broader commitment in the industry to advance care, innovation, and patient success in the fight against substance use disorders.
